[{"address1": "3710 \u2013 33rd Street NW", "city": "Calgary", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403-455-7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 64, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 391655, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Scott Bumby D.V.M., M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 6515, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 74, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 110445, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 50, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 157500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 54, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 60, "title": "Consultant of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7226, "open": 0.7226, "dayLow": 0.6608, "dayHigh": 0.7499, "regularMarketPreviousClose": 0.7226, "regularMarketOpen": 0.7226, "regularMarketDayLow": 0.6608, "regularMarketDayHigh": 0.7499, "payoutRatio": 0.0, "beta": -0.017, "forwardPE": -0.43443114, "volume": 177342, "regularMarketVolume": 177342, "averageVolume": 102720, "averageVolume10days": 78040, "averageDailyVolume10Day": 78040, "bid": 0.7147, "ask": 0.7501, "bidSize": 1, "askSize": 1, "marketCap": 3667670, "fiftyTwoWeekLow": 0.6608, "fiftyTwoWeekHigh": 2.98, "fiftyDayAverage": 0.88812, "twoHundredDayAverage": 1.05976, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 868796, "profitMargins": 0.0, "floatShares": 3687100, "sharesOutstanding": 5055370, "sharesShort": 160274, "sharesShortPriorMonth": 2807, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0423, "heldPercentInsiders": 0.03621, "heldPercentInstitutions": 0.04711, "shortRatio": 0.7, "shortPercentOfFloat": 0.044099998, "impliedSharesOutstanding": 5312750, "bookValue": 0.724, "priceToBook": 1.0020719, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -993083, "trailingEps": -0.1, "forwardEps": -1.67, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -0.313, "52WeekChange": -0.53757966, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 0.7255, "targetHighPrice": 14.528836, "targetLowPrice": 14.528836, "targetMeanPrice": 14.528836, "targetMedianPrice": 14.528836, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1895238, "totalCashPerShare": 0.5, "ebitda": -2773296, "totalDebt": 15662, "quickRatio": 2.525, "currentRatio": 2.777, "debtToEquity": 0.571, "returnOnAssets": -0.36498, "returnOnEquity": -0.37959, "freeCashflow": -559253, "operatingCashflow": -3018526, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "XRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754085514, "regularMarketTime": 1754078400, "exchange": "NCM", "messageBoardId": "finmb_259860883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.401329, "regularMarketPrice": 0.7255, "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1632403800000, "postMarketChangePercent": 1.86079, "postMarketPrice": 0.739, "postMarketChange": 0.0135, "regularMarketChange": 0.0029, "regularMarketDayRange": "0.6608 - 0.7499", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 102720, "fiftyTwoWeekLowChange": 0.06470001, "fiftyTwoWeekLowChangePercent": 0.09791163, "fiftyTwoWeekRange": "0.6608 - 2.98", "fiftyTwoWeekHighChange": -2.2545, "fiftyTwoWeekHighChangePercent": -0.7565436, "fiftyTwoWeekChangePercent": -53.757965, "earningsTimestamp": 1747339200, "earningsTimestampStart": 1755088200, "earningsTimestampEnd": 1755088200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.1, "epsForward": -1.67, "epsCurrentYear": -1.574, "priceEpsCurrentYear": -0.46092758, "fiftyDayAverageChange": -0.16262001, "fiftyDayAverageChangePercent": -0.1831059, "twoHundredDayAverageChange": -0.33426, "twoHundredDayAverageChangePercent": -0.31541103, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "marketState": "CLOSED", "displayName": "XORTX Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]